Serine phosphorylation sites on IRS2 activated by angiotensin II and protein kinase C to induce selective insulin resistance in endothelial cells

Molecular and Cellular Biology

Volumn 33, Issue 16, 2013, Pages 3227-3241

  Park, Kyoungmin ^a   Li, Qian ^a   Rask Madsen, Christian ^a   Mima, Akira ^a   Mizutani, Koji ^a   Winnay, Jonathon ^a   Maeda, Yasutaka ^a   D'Aquino, Katharine ^b   White, Morris F ^b   Feener, Edward P ^a   King, George L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; ENDOTHELIAL NITRIC OXIDE SYNTHASE; LOSARTAN; MYRISTIC ACID; PHORBOL ESTER; PROTEIN KINASE B; PROTEIN KINASE C; PROTEIN KINASE C BETA; SERINE; TYROSINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; INSULIN RESISTANCE; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT;

ANGIOTENSIN II; ANIMALS; CATTLE; CELL LINE; ENDOTHELIAL CELLS; ENZYME ACTIVATION; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; MALE; MICE; MICE, TRANSGENIC; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTEIN KINASE C; RATS; RATS, ZUCKER; SERINE; TETRADECANOYLPHORBOL ACETATE; THREONINE; TYROSINE;

EID: 84881307201     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00506-13     Document Type: Article

References (42)

1. Despres JP, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S, Lupien PJ. 1996. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N. Engl. J. Med. 334:952-957.
2. Howard G, O'Leary DH, Zaccaro D, Haffner S, Rewers M, Hamman R, Selby JV, Saad MF, Savage P, Bergman R. 1996. Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Circulation 93:1809-1817.
3. Geraldes P, Yagi K, Ohshiro Y, He Z, Maeno Y, Yamamoto-Hiraoka J, Rask-Madsen C, Chung SW, Perrella MA, King GL. 2008. Selective regulation of heme oxygenase-1 expression and function by insulin through IRS1/phosphoinositide 3-kinase/Akt-2 pathway. J. Biol. Chem. 283:34327-34336.
4. Rask-Madsen C, Li Q, Freund B, Feather D, Abramov R, Wu IH, Chen K, Yamamoto-Hiraoka J, Goldenbogen J, Sotiropoulos KB, Clermont A, Geraldes P, Dall'Osso C, Wagers AJ, Huang PL, Rekhter M, Scalia R, Kahn CR, King GL. 2010. Loss of insulin signaling in vascular endothelial cells accelerates atherosclerosis in apolipoprotein E null mice. Cell Metab. 11:379-389.
5. Boden G. 1997. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46:3-10.
6. Feener EP, King GL. 1997. Vascular dysfunction in diabetes mellitus. Lancet 350(Suppl. 1):SI9 -SI13.
7. Maeno Y, Li Q, Park K, Rask-Madsen C, Gao B, Matsumoto M, Liu Y, Wu IH, White MF, Feener EP, King GL. 2012. Inhibition of insulin signaling in endothelial cells by protein kinase C-induced phosphorylation of p85 subunit of phosphatidylinositol 3-kinase (PI3K). J. Biol. Chem. 287:4518-4530.
8. Venieratos PD, Drossopoulou GI, Kapodistria KD, Tsilibary EC, Kitsiou PV. 2010. High glucose induces suppression of insulin signalling and apoptosis via upregulation of endogenous IL-1beta and suppressor of cytokine signalling-1 in mouse pancreatic beta cells. Cell Signal 22:791-800.
9. Lee AV, Gooch JL, Oesterreich S, Guler RL, Yee D. 2000. Insulin-like growth factor I-induced degradation of insulin receptor substrate 1 is mediated by the 26S proteasome and blocked by phosphatidylinositol 3=-kinase inhibition. Mol. Cell. Biol. 20:1489-1496.
10. Rui L, Yuan M, Frantz D, Shoelson S, White MF. 2002. SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J. Biol. Chem. 277:42394-42398.
11. Boura-Halfon S, Zick Y. 2009. Phosphorylation of IRS proteins, insulin action, and insulin resistance. Am. J. Physiol. Endocrinol. Metab. 296: E581-E591.
12. Hanke S, Mann M. 2009. The phosphotyrosine interactome of the insulin receptor family and its substrates IRS-1 and IRS-2. Mol. Cell. Proteomics 8:519-534.
13. Greene MW, Garofalo RS. 2002. Positive and negative regulatory role of insulin receptor substrate 1 and 2 (IRS-1 and IRS-2) serine/threonine phosphorylation. Biochemistry 41:7082-7091.
14. Mothe I, Van Obberghen E. 1996. Phosphorylation of insulin receptor substrate-1 on multiple serine residues, 612, 632, 662, and 731, modulates insulin action. J. Biol. Chem. 271:11222-11227.
15. Aguirre V, Uchida T, Yenush L, Davis R, White MF. 2000. The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J. Biol. Chem. 275:9047-9054.
16. Rui L, Aguirre V, Kim JK, Shulman GI, Lee A, Corbould A, Dunaif A, White MF. 2001. Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways. J. Clin. Invest. 107:181-189.
17. Waraich RS, Weigert C, Kalbacher H, Hennige AM, Lutz SZ, Haring HU, Schleicher ED, Voelter W, Lehmann R. 2008. Phosphorylation of Ser357 of rat insulin receptor substrate-1 mediates adverse effects of protein kinase C-delta on insulin action in skeletal muscle cells. J. Biol. Chem. 283:11226-11233.
18. Zhang J, Gao Z, Yin J, Quon MJ, Ye J. 2008. S6K directly phosphorylates IRS-1 on Ser-270 to promote insulin resistance in response to TNF- (alpha) signaling through IKK2. J. Biol. Chem. 283:35375-35382.
19. Blom N, Gammeltoft S, Brunak S. 1999. Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. J. Mol. Biol. 294: 1351-1362.
20. Das Evcimen N, King GL. 2007. The role of protein kinase C activation and the vascular complications of diabetes. Pharmacol. Res. 55:498-510.
21. Mima A, Hiraoka-Yamomoto J, Li Q, Kitada M, Li C, Geraldes P, Matsumoto M, Mizutani K, Park K, Cahill C, Nishikawa S, Rask- Madsen C, King GL. 2012. Protective effects of GLP-1 on glomerular endothelium and its inhibition by PKCbeta activation in diabetes. Diabetes 61:2967-2979.
22. Naruse K, Rask-Madsen C, Takahara N, Ha SW, Suzuma K, Way KJ, Jacobs JR, Clermont AC, Ueki K, Ohshiro Y, Zhang J, Goldfine AB, King GL. 2006. Activation of vascular protein kinase C-beta inhibits Aktdependent endothelial nitric oxide synthase function in obesity-associated insulin resistance. Diabetes 55:691-698.
23. Taguchi K, Kobayashi T, Matsumoto T, K Kamata. 2011. Dysfunction of endothelium-dependent relaxation to insulin via PKC-mediated GRK2/ Akt activation in aortas of ob/ob mice. Am. J. Physiol. Heart Circ. Physiol. 301:H571-H583.
24. Harja E, Chang JS, Lu Y, Leitges M, Zou YS, Schmidt AM, Yan SF. 2009. Mice deficient in PKCbeta and apolipoprotein E display decreased atherosclerosis. FASEB J. 23:1081-1091.
25. Feener EP, King GL. 2001. Endothelial dysfunction in diabetes mellitus: role in cardiovascular disease. Heart Fail Monit. 1:74-82.
26. Jiang ZY, Lin YW, Clemont A, Feener EP, Hein KD, Igarashi M, Yamauchi T, White MF, King GL. 1999. Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats. J. Clin. Invest. 104:447-457.
27. Mima A, Ohshiro Y, Kitada M, Matsumoto M, Geraldes P, Li C, Li Q, White GS, Cahill C, Rask-Madsen C, King GL. 2011. Glomerularspecific protein kinase C-beta-induced insulin receptor substrate-1 dysfunction and insulin resistance in rat models of diabetes and obesity. Kidney Int. 79:883-896.
28. Symons JD, McMillin SL, Riehle C, Tanner J, Palionyte M, Hillas E, Jones D, Cooksey RC, Birnbaum MJ, McClain DA, Zhang QJ, Gale D, Wilson LJ, Abel ED. 2009. Contribution of insulin and Akt1 signaling to endothelial nitric oxide synthase in the regulation of endothelial function and blood pressure. Circ. Res. 104:1085-1094.
29. Tabit CE, Shenouda SM, Holbrook M, Fetterman JL, Kiani S, Frame AA, Kluge MA, Held A, Dohadwala MM, Gokce N, Farb MG, Rosenzweig J, Ruderman N, Vita JA, Hamburg NM. 2013. Protein kinase C-beta contributes to impaired endothelial insulin signaling in humans with diabetes mellitus. Circulation 127:86-95.
30. Aguirre V, Werner ED, Giraud J, Lee YH, Shoelson SE, White MF. 2002. Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J. Biol. Chem. 277:1531-1537.
31. Liu YF, Herschkovitz A, Boura-Halfon S, Ronen D, Paz K, Leroith D, Zick Y. 2004. Serine phosphorylation proximal to its phosphotyrosine binding domain inhibits insulin receptor substrate 1 function and promotes insulin resistance. Mol. Cell. Biol. 24:9668-9681.
32. Tseng YH, Kriauciunas KM, Kokkotou E, Kahn CR. 2004. Differential roles of insulin receptor substrates in brown adipocyte differentiation. Mol. Cell. Biol. 24:1918-1929.
33. Tseng YH, Ueki K, Kriauciunas KM, Kahn CR. 2002. Differential roles of insulin receptor substrates in the anti-apoptotic function of insulin-like growth factor-1 and insulin. J. Biol. Chem. 277:31601-31611.
34. Kubota T, Kubota N, Kumagai H, Yamaguchi S, Kozono H, Takahashi T, Inoue M, Itoh S, Takamoto I, Sasako T, Kumagai K, Kawai T, Hashimoto S, Kobayashi T, Sato M, Tokuyama K, Nishimura S, Tsunoda M, Ide T, Murakami K, Yamazaki T, Ezaki O, Kawamura K, Masuda H, Moroi M, Sugi K, Oike Y, Shimokawa H, Yanagihara N, Tsutsui M, Terauchi Y, Tobe K, Nagai R, Kamata K, Inoue K, Kodama T, Ueki K, Kadowaki T. 2011. Impaired insulin signaling in endothelial cells reduces insulin-induced glucose uptake by skeletal muscle. Cell Metab. 13:294-307.
35. Gual P, Gremeaux T, Gonzalez T, Le Marchand-Brustel Y, Tanti JF. 2003. MAP kinases and mTOR mediate insulin-induced phosphorylation of insulin receptor substrate-1 on serine residues 307, 612 and 632. Diabetologia 46:1532-1542.
36. Liberman Z, Eldar-Finkelman H. 2005. Serine 332 phosphorylation of insulin receptor substrate-1 by glycogen synthase kinase-3 attenuates insulin signaling. J. Biol. Chem. 280:4422-4428.
37. He W, Craparo A, Zhu Y, O'Neill TJ, Wang LM, Pierce JH, Gustafson TA. 1996. Interaction of insulin receptor substrate-2 (IRS-2) with the insulin and insulin-like growth factor I receptors. Evidence for two distinct phosphotyrosine-dependent interaction domains within IRS-2. J. Biol. Chem. 271:11641-11645.
38. Park SY, Shoelson SE. 2008. When a domain is not a domain. Nat. Struct. Mol. Biol. 15:224-226.
39. Wu J, Tseng YD, Xu CF, Neubert TA, White MF, Hubbard SR. 2008. Structural and biochemical characterization of the KRLB region in insulin receptor substrate-2. Nat. Struct. Mol. Biol. 15:251-258.
40. Sharfi H, Eldar-Finkelman H. 2008. Sequential phosphorylation of insulin receptor substrate-2 by glycogen synthase kinase-3 and c-Jun NH2- terminal kinase plays a role in hepatic insulin signaling. Am. J. Physiol. Endocrinol. Metab. 294:E307-E315.
41. Solinas G, Naugler W, Galimi F, Lee MS, Karin M. 2006. Saturated fatty acids inhibit induction of insulin gene transcription by JNK-mediated phosphorylation of insulin-receptor substrates. Proc. Natl. Acad. Sci. U. S. A. 103:16454-16459.
42. Igarashi M, Wakasaki H, Takahara N, Ishii H, Jiang ZY, Yamauchi T, Kuboki K, Meier M, Rhodes CJ, King GL. 1999. Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways. J. Clin. Invest. 103:185-195.